[1]
2024. Clinical Evaluation of the Significance of FGFR2/3 Genomic Alterations in Urothelial Cancer: A Retrospective Analysis. Voprosy onkologii. 70, 4 (Sep. 2024), 685–695. DOI:https://doi.org/10.37469/0507-3758-2024-70-4-685-695.